MetaCap
October 8, 2026

How to Value a Stock: Methods and Formulas

Learn intrinsic value, valuation methods (DCF, comparable company, asset-based) and how analysts estimate a "fair price".

Key Takeaways

  • •Intrinsic value is what a stock is "worth" based on fundamental analysis; market price is what it trades for
  • •Discounted Cash Flow (DCF) values stock by discounting future cash flows to present value
  • •Comparable Company valuation uses P/E, price-to-sales, or EV/EBITDA ratios of similar companies
  • •Asset-based valuation values the company based on its balance sheet (useful for banks, real estate)
  • •No valuation method is perfect; use multiple methods and compare

Stock valuation is the process of estimating a company's intrinsic value—what the stock is "worth" based on financial analysis. If intrinsic value > market price, the stock may be undervalued. If intrinsic value < market price, it may be overvalued. There are multiple valuation methods, each with strengths and weaknesses. Professional investors use several together.

What Is Intrinsic Value?

Intrinsic value is a company's fundamental worth, independent of its stock price. It is based on:

  • Future earnings and cash flow
  • Growth rate
  • Risk (discount rate)
  • Competitive moat
  • Management quality

Two people can have different intrinsic value estimates for the same stock based on different assumptions.

Method 1: Discounted Cash Flow (DCF)

DCF values a company based on the present value of its future free cash flows.

Steps:

  1. Forecast FCF for 10 years based on historical growth and expected growth.
  2. Calculate terminal value (value of cash flows after year 10, assuming stable growth).
  3. Choose a discount rate (typically 8-12%, depending on risk). This is the rate you require to invest.
  4. Discount all cash flows to present value.
  5. Divide by shares outstanding to get per-share intrinsic value.

Example:

  • AAPL projected to generate $100B FCF in year 1, growing 8% per year for 10 years.
  • Terminal growth rate: 2.5%.
  • Discount rate: 10% (reflecting Apple's risk).
  • Calculated intrinsic value: $180 per share (example).
  • Current market price: $190.
  • Conclusion: Fairly valued or slightly expensive.

Strengths: Theoretically sound, based on cash flows. Weaknesses: Highly dependent on assumptions. Small changes in growth rate or discount rate lead to big valuation swings.

Method 2: Comparable Company Valuation

This method values a company by comparing it to similar publicly traded companies.

Steps:

  1. Identify peer companies in the same industry.
  2. Calculate valuation multiples for peers: P/E, Price-to-Sales (P/S), EV/EBITDA, Price-to-Book.
  3. Apply the median multiple to your company's metrics to estimate value.

Example:

  • Peer software companies trade at an average P/E of 35x.
  • Your company has EPS of $5.
  • Estimated stock value = $5 × 35 = $175 per share.

Common multiples:

  • P/E: Stock price ÷ earnings per share. Higher for growth, lower for value.
  • EV/EBITDA: Enterprise value (market cap + debt - cash) ÷ EBITDA (earnings before interest, taxes, depreciation). Less affected by capital structure.
  • Price-to-Sales: Less affected by accounting tricks than P/E. Useful for unprofitable companies.
  • Price-to-Book: Value per dollar of book value. Used for banks and asset-heavy companies.

Strengths: Simple, market-based, reflects market consensus. Weaknesses: Assumes peers are fairly valued. If the whole sector is overvalued, you'll overvalue your company.

Method 3: Asset-Based Valuation

This method values a company based on its balance sheet: assets minus liabilities.

Intrinsic Value = Total Assets - Total Liabilities = Shareholders' Equity

Per-share value = Shareholders' Equity ÷ Shares Outstanding

This is also called "Book Value."

Used for:

  • Banks and financial institutions (assets are loans, investments).
  • Real estate companies and REITs (assets are properties).
  • Insurance companies (assets are reserves and investments).

Example:

  • Bank has $500B in assets, $450B in liabilities.
  • Shareholders' equity = $50B.
  • 5B shares outstanding.
  • Book value per share = $50B ÷ 5B = $10.
  • If the bank trades at $15, it's at 1.5x book value (P/B ratio of 1.5).

Strengths: Conservative, based on hard assets. Weaknesses: Ignores earnings power and growth. A company can be worth much more than its book value if it's very profitable. Also, asset values can be misleading (outdated property, hidden liabilities).

Method 4: Dividend Discount Model (DDM)

For dividend-paying stocks, you can value the stock as the present value of all future dividends.

Simplified formula (assuming constant growth):

Intrinsic Value = Annual Dividend ÷ (Discount Rate - Dividend Growth Rate)

Example:

  • JNJ pays $2.80 per share annually.
  • Discount rate: 8%.
  • Expected dividend growth: 4% per year.
  • Intrinsic value = $2.80 ÷ (0.08 - 0.04) = $2.80 ÷ 0.04 = $70 per share.

This method is simple but assumes constant growth forever, which is unrealistic.

Combining Methods: A Real Example

Let's value Microsoft (MSFT) using multiple methods:

Method 1 (DCF): Calculate intrinsic value = $380. Method 2 (Comparable): Peers trade at 42x earnings; MSFT EPS = $11 → value = $462. Method 3 (Asset): Book value = $220 per share (less relevant for software). Method 4 (DDM): Not useful; MSFT pays minimal dividend.

Range of values: $220 to $462. The midpoint is $340. Current market price: $420.

Conclusion: MSFT is likely overvalued vs. DCF and asset valuation, but close to peers' valuations. Depends on growth assumptions and risk tolerance.

Choosing the Right Discount Rate

The discount rate (WACC—Weighted Average Cost of Capital) reflects the risk of the company:

  • Low-risk utilities: 6-8%
  • Stable blue-chips: 8-10%
  • Growth stocks: 10-12%
  • High-risk/startup: 12-15%+

Higher discount rates = more risk = lower valuations.

Common Misconceptions

"Intrinsic value is always correct": It's an estimate based on assumptions. Two analysts can have vastly different intrinsic values.

"I should only buy stocks trading below intrinsic value": True in principle, but intrinsic value is uncertain. Some prefer a "margin of safety" (buy at 70% of intrinsic value).

"High P/E means expensive": Not always. A high-growth company with a P/E of 60 might be cheaper than a slow-growth company with P/E of 20, based on growth and risk.

Key Takeaways

  • Intrinsic value is a company's fundamental worth, independent of market price.
  • DCF values based on future cash flows; theoretically sound but assumption-dependent.
  • Comparable company uses peer multiples; market-based but assumes peers are fairly valued.
  • Asset-based values from the balance sheet; useful for banks and real estate.
  • Dividend discount values based on dividend streams; useful for dividend stocks.
  • Use multiple methods and compare; if they agree, you have more confidence.
  • Small changes in assumptions (growth rate, discount rate) lead to large valuation swings.

Frequently Asked Questions

What is intrinsic value?

Intrinsic value is what you believe a stock is worth based on analysis of earnings, cash flow, growth, and risk. If intrinsic value is $100 but the stock trades at $70, you have a margin of safety (it's potentially undervalued).

Which valuation method is most reliable?

None is perfect. DCF is theoretically sound but depends heavily on assumptions. Comparable company valuation is simple but assumes peers are fairly priced. Use multiple methods; if they agree, you have more confidence.

How do I forecast future cash flows for DCF?

Look at historical cash flow growth. If a company has grown FCF 15% for 5 years, project it forward 10 years (being conservative; usually assume slowdown over time). Then assume a "terminal growth rate" (2-3%) for cash flow after year 10.

Why do analysts have different price targets?

Different assumptions: growth rates, discount rates, terminal value multiples. Small changes in assumptions can lead to 20-50% differences in valuations. This is why analyst consensus matters—averaging out differences.

Related Stocks

Sources

Author: metacap-editorial-team

Last reviewed: October 8, 2026